SCHEMBL15614213

SCHEMBL15614213

c1ccc(-c2ccc(-c3cccc(-c4cc(-n5c6ccccc6c6c7sc8ccccc8c7ccc65)nc5ccccc45)c3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.37
EGFR P00533 1/20 0.37
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 4/20 0.35
LMNA P02545 3/20 0.35
HTT P42858 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PRKDC P78527 2/20 0.33
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
LIMK1 P53667 2/20 0.31
PIM3 Q86V86 1/20 0.30
TNKS O95271 1/20 0.30
TNKS2 Q9H2K2 1/20 0.30
ACACA Q13085 1/20 0.30
NPC1 O15118 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17050898 0.99 EGFR (0.37) ALOX5EGFRKDM4EALDH1A1HPGD
SCHEMBL15614119 0.98 EGFR (0.39) ALOX5EGFRKDM4EALDH1A1HPGD
SCHEMBL14979045 0.95 EGFR (0.41) ALOX5EGFRKDM4EALDH1A1HPGD
SCHEMBL15614112 0.93 EGFR (0.37) ALOX5EGFRKDM4EALDH1A1HPGD
SCHEMBL24450488 0.93 EGFR (0.43) ALOX5EGFRKDM4EALDH1A1HPGD
SCHEMBL15614048 0.92 EGFR (0.40) ALOX5EGFRKDM4EALDH1A1HPGD
SCHEMBL15614092 0.92 EGFR (0.40) ALOX5EGFRKDM4EALDH1A1HPGD
SCHEMBL15614070 0.92 EGFR (0.40) ALOX5EGFRKDM4EALDH1A1HPGD
SCHEMBL15614109 0.91 EGFR (0.35) ALOX5EGFRKDM4EALDH1A1HPGD
SCHEMBL17050904 0.88 KDM4E (0.35) ALOX5EGFRKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150249224-A1 NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2015-09-03 US disclosed
US-20150249224-A1 NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2015-09-03 US disclosed
WO-2014042405-A1 A NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2014-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150249224-A1 NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME TYR, DDT, COMT ALOX5 2806/4885EGFR 3475/4885KDM4E 2488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.